Singapore, Feb. 12 -- Prenetics Global Limited, a leading genomics-driven health sciences company, has announced the signing of a Memorandum of Understanding (MoU), that paves the way for a strategic investment in Metavisionaries and a pioneering five-year research agreement with them and their partners Space Application Services through their Metaspace Venture.

The parties will also establish a Space Innovation Lab within the UAE Space Agency. The inaugural Prenetics research cube is scheduled to on-board the SpaceX to the ISS in Q4 of 2024.

As space exploration ignites a new era of discovery, the first endeavour by Prenetics will be with the Botnar Institute for Musculoskeletal Sciences at the University of Oxford, NDORMS (Nuffield De...